UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 196 filers reported holding NEVRO CORP in Q2 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2024$3,650,390
+548.8%
433,538
+1012.7%
0.00%
Q1 2024$562,597
-32.9%
38,9610.0%0.00%
Q4 2023$838,440
+12.0%
38,9610.0%0.00%
Q3 2023$748,831
-43.6%
38,961
+6.2%
0.00%
-100.0%
Q2 2023$1,326,6320.0%36,6980.0%0.00%0.0%
Q1 2023$1,326,632
-8.7%
36,6980.0%0.00%0.0%
Q4 2022$1,453,242
-99.9%
36,698
+5.7%
0.00%0.0%
Q3 2022$1,617,907,000
-15.0%
34,719
-20.1%
0.00%0.0%
Q2 2022$1,904,238,000
-40.8%
43,446
-2.3%
0.00%0.0%
Q1 2022$3,217,239,000
+5.0%
44,480
+17.7%
0.00%0.0%
Q4 2021$3,064,770,000
-29.7%
37,804
+0.9%
0.00%
-50.0%
Q3 2021$4,359,014,000
-30.7%
37,455
-1.2%
0.00%
-33.3%
Q2 2021$6,287,088,000
+19.9%
37,922
+0.9%
0.00%
+50.0%
Q1 2021$5,244,505,000
-18.7%
37,595
+0.8%
0.00%
-33.3%
Q4 2020$6,453,687,000
+30.4%
37,283
+4.9%
0.00%0.0%
Q3 2020$4,949,748,000
+20.2%
35,533
+3.1%
0.00%0.0%
Q2 2020$4,118,011,000
+15.3%
34,469
-3.5%
0.00%0.0%
Q1 2020$3,572,785,000
-10.0%
35,735
+5.7%
0.00%
+50.0%
Q4 2019$3,971,912,000
+37.2%
33,792
+0.4%
0.00%0.0%
Q3 2019$2,894,353,000
+66.6%
33,667
+25.6%
0.00%
+100.0%
Q2 2019$1,737,444,000
+35.8%
26,800
+30.9%
0.00%0.0%
Q1 2019$1,279,830,000
+229.1%
20,474
+104.7%
0.00%
Q4 2018$388,900,000
-64.2%
10,000
-47.5%
0.00%
-100.0%
Q3 2018$1,084,995,000
-26.5%
19,035
+2.9%
0.00%0.0%
Q2 2018$1,476,427,000
-2.6%
18,490
+5.8%
0.00%0.0%
Q1 2018$1,515,339,000
+46.4%
17,484
+16.6%
0.00%0.0%
Q4 2017$1,034,910,000
-28.0%
14,990
-5.2%
0.00%0.0%
Q3 2017$1,437,630,000
+49.4%
15,819
+22.3%
0.00%0.0%
Q2 2017$962,380,000
-9.9%
12,930
+13.5%
0.00%0.0%
Q1 2017$1,067,899,000
+350030.8%
11,397
+171.4%
0.00%
Q4 2016$305,000
-73.2%
4,200
-61.5%
0.00%
-100.0%
Q3 2016$1,139,000
+93.1%
10,908
+36.4%
0.00%0.0%
Q2 2016$590,000
+47.9%
8,000
+12.7%
0.00%
Q1 2016$399,000
+9.3%
7,100
+31.5%
0.00%
Q4 2015$365,000
+57.3%
5,400
+8.0%
0.00%
Q3 2015$232,000
-13.8%
5,0000.0%0.00%
Q2 2015$269,0005,0000.00%
Other shareholders
NEVRO CORP shareholders Q2 2018
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$45,155,2751.48%
ARMISTICE CAPITAL, LLC 2,356,000$59,889,5200.87%
Rock Springs Capital Management LP 1,211,400$30,793,7880.73%
ArrowMark Colorado Holdings LLC 1,817,189$46,192,9440.51%
Palo Alto Investors LP 186,259$4,734,7040.38%
K2 PRINCIPAL FUND, L.P. 51,000$1,296,4200.30%
TD Capital Management LLC 84,648$2,151,7520.26%
Point72 Europe (London) LLP 73,800$1,875,9960.25%
Venator Management LLC 25,000$6360.23%
Virtus Investment Advisers, Inc. 12,500$317,7500.22%
View complete list of NEVRO CORP shareholders